ArticleApplied health economics and health policy2024
Public Preference for Off-Label Use of Drugs for Cancer Treatment and Relative Importance of Associated Adverse Events: A Discrete Choice Experiment and Best-Worst Scaling.
Kailu Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.